Mansinho K - Search Results

1

Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients.

Marcelino R, Gramacho F, Martin F, Brogueira P, Janeiro N, Afonso C, Badura R, Valadas E, Mansinho K, Caldeira L, Taveira N, Marcelino JM. Marcelino R, et al. Among authors: mansinho k. Sci Rep. 2021 Apr 26;11(1):8993. doi: 10.1038/s41598-021-88274-9. Sci Rep. 2021. PMID: 33903642 Free PMC article.

2

Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients.

Abecasis AB, Martins A, Costa I, Carvalho AP, Diogo I, Gomes P, Camacho RJ; Portuguese Hiv-1 Resistance Study Group. Abecasis AB, et al. AIDS Res Hum Retroviruses. 2011 Jul;27(7):803-5. doi: 10.1089/AID.2010.0312. Epub 2011 Feb 16. AIDS Res Hum Retroviruses. 2011. PMID: 21198411

3

Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.

Cavaco-Silva J, Aleixo MJ, Van Laethem K, Faria D, Valadas E, Gonçalves Mde F, Gomes P, Vandamme AM, Cunha C, Camacho RJ; Portuguese HIV-2 Resistance Study Group. Cavaco-Silva J, et al. J Antimicrob Chemother. 2013 Jan;68(1):190-2. doi: 10.1093/jac/dks363. Epub 2012 Sep 13. J Antimicrob Chemother. 2013. PMID: 22977160

4

HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.

Cavaco-Silva J, Abecasis A, Miranda AC, Poças J, Narciso J, Águas MJ, Maltez F, Almeida I, Germano I, Diniz A, Gonçalves Mde F, Gomes P, Cunha C, Camacho RJ; Portuguese HIV-2 Resistance Study Group. Cavaco-Silva J, et al. PLoS One. 2014 Mar 28;9(3):e92747. doi: 10.1371/journal.pone.0092747. eCollection 2014. PLoS One. 2014. PMID: 24681625 Free PMC article.

5

Improve screening of HCV infection by targeting high prevalence aged groups: analysis of a cohort of HCV and HIV co-infected patients.

Brogueira P, Costa A, Miranda A, Peres S, Baptista T, Aldir I, Antunes I, Ventura F, Borges F, Mansinho K. Brogueira P, et al. Among authors: mansinho k. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19601. doi: 10.7448/IAS.17.4.19601. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394105 Free PMC article.

6

Evolution trends over three decades of HIV infection late diagnosis: the experience of a Portuguese cohort of 705 HIV-infected patients.

Miranda AC, Moneti V, Brogueira P, Peres S, Baptista T, Aldir I, Ventura F, Borges F, Mansinho K. Miranda AC, et al. Among authors: mansinho k. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19688. doi: 10.7448/IAS.17.4.19688. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397438 Free PMC article.

7

Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort.

Brandão R, Marcelino R, Gonçalves F, Diogo I, Carvalho A, Cabanas J, Costa I, Brogueira P, Ventura F, Miranda A, Mansinho K, Gomes P. Brandão R, et al. Among authors: mansinho k. Viruses. 2018 Apr 26;10(5):223. doi: 10.3390/v10050223. Viruses. 2018. PMID: 29701642 Free PMC article.

8

Determinants of HIV-1 Late Presentation in a Cohort of Portuguese HIV-1 Patients.

Miranda AC, Miranda M, Pingarilho M, Pimentel V, Torres J, Peres S, Baptista Alberto T, Gomes P, Abecasis A, Mansinho K. Miranda AC, et al. Among authors: mansinho k. AIDS Res Hum Retroviruses. 2021 Nov;37(11):846-851. doi: 10.1089/AID.2020.0175. Epub 2021 Feb 16. AIDS Res Hum Retroviruses. 2021. PMID: 33461392

9

Safety and Efficacy of Triple Therapy With Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Human Immunodeficiency Virus Type 2 Patients: Results From a 48-Week Phase 2 Study.

Pacheco P, Marques N, Rodrigues P, Mansinho K, Maltez F, Janeiro N, Franco C, Trigo D, Batista J, Duque L, Lopes MJ, Aleixo MJ, Silva AR, Tavares R, Alves J, Peres S, Póvoas D, Lino S, Gomes P, Araújo V, Lopes C. Pacheco P, et al. Among authors: mansinho k. Clin Infect Dis. 2023 Sep 11;77(5):740-748. doi: 10.1093/cid/ciad339. Clin Infect Dis. 2023. PMID: 37288954 Clinical Trial.

10

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHT-ESPRIT Study Group. Pett SL, et al. HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31. HIV Med. 2011. PMID: 20812949 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page